Scandinavian ChemoTech AB meddelar idag att Bolaget erhållit godkännande från det europeiska patentverket. Slutföreläggandet för denna patentansökan meddelades i ett pressmeddelande den 3 februari 2021. Granskaren kungör att godkännandet publiceras den 7 juli 2021.
Read moreEfter att Scandinavian ChemoTech AB (publ) idag mottagit en signerad elektronisk kopia av sitt CE-certifikat, ökar nu Bolaget sin orderbok med ytterligare ca 0,7 MSEK.
Read moreScandinavian ChemoTech AB (publ) (“ChemoTech”) meddelar idag att Martin Jerndal, styrelseledamot, har köpt 3 980 aktier för cirka 112 000 SEK över börsen. Hans totala innehav uppgår nu till 582 695 aktier i ChemoTech.
Read moreScandinavian ChemoTech AB announces today that the Company has received approval from the European Patent Office. The final injunction for this patent application was announced in a press release on the 3[d ]of February 2021. The examiner announces that the approval will be published 7[th] of July 2021.
Read moreScandinavian ChemoTech AB (publ) (“ChemoTech”) announces today that Martin Jerndal, board member, has bought 3,980 shares for approximately SEK 112,000 over the stock exchange. His total holding now amounts to 582,695 shares in ChemoTech.
Read moreScandinavian ChemoTech AB (publ) (“ChemoTech”) announces today that Bengt Engström, board member, has bought 5,000 shares for approximately SEK 162,500 over the stock exchange. His total holding now amounts to 43,000 shares in ChemoTech. Rolf Ehrnström, board member, has bought 10,000 shares for approximately SEK 326,000 over the stock exchange. His total holding now amounts…
Read more
